Risedronate (Na)
Risedronate (Na) Information

About Risedronate (Na)

Risedronate (Na) is a bisphosphate with similar properties to those of bisphosphonates in general. It inhibits bone resorption and is used in Paget"s diseaseof bone and in the treatment of post-menopausal osteoporosis to redce risk of vertebral or hip fractures.

Indications

Risedronate (Na) is primarily indicated in conditions like Pagets disease, Paget's disease of bone, Postmenopausal osteoporosis.

Contraindication

Risedronate (Na)

Side Effects

The symptomatic adverse reactions produced by Risedronate (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Constipation, Abdominal pain, Nausea and vomiting.

Warnings

Hypocalcemia should be corrected before beginning therapy. Tablets should be taken on rising for the day, on an empty stomach, atleast 30 minutes before breakfast and other oral drug. To minimize the gastro-intestinal effects of the drug patients should be instructed to swallow tablety with plenty of water in an upright position (standing or sitting). Patient should remain upright after taking the tablet and should not lie down for at least 30 minutes.

High Risk Groups

Drug should not be given to Pregnant Mothers, and patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.